REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Siegfried S.A.S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Siegfried S.A.S Profile Updated: October 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratories Siegfried S.A.S. is a company focused on the development, production and marketing of pharmaceutical, dermatological and nutritional products, which began operations in Colombia in 2008.

Headquarters
Calle 17 # 42 09
Bogota D.C.; Bogota D.C; Postal Code: 0607

Contact Details: Purchase the Laboratorios Siegfried S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Siegfried S.A.S report to view the information.
Outstanding Shares:
Purchase the Laboratorios Siegfried S.A.S report to view the information.
Incorporation Date:
July 02, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Subsidiaries
Laboratorios Metlen Pharma S A S
Laboratorios Siegfried S A
Laboratorios Siegfried S A C
Company Performance
Financial values in the chart are available after Laboratorios Siegfried S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
19.31%▲
Total operating revenue
20.49%▲
Operating profit (EBIT)
20.63%▲
EBITDA
23.2%▲
Net Profit (Loss) for the Period
44.04%▲
Total assets
17.01%▲
Total equity
13.49%▲
Operating Profit Margin (ROS)
0.33%▲
Net Profit Margin
3.64%▲
Return on Equity (ROE)
4.6%▲
Debt to Equity Ratio
8.11%▲
Quick Ratio
-0.28%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo